The Promise of Individualized HIV Prevention: Future Formulations and Dosing Intervals for Long-Acting PrEP
In this podcast, CCO’s expert faculty provides an overview of the different antiretroviral drug formulations and dosing strategies in various stages of clinical development for long-acting HIV PrEP—advances that collectively offer the potential for highly individualized approaches to HIV biomedical prevention.